About Del Trade
Del Trade is a company based in Delhi (India) founded in 2010 by Nitin Aggarwal. It operates as a B2B. The company has 66 employees. Del Trade operates in a competitive market with competitors including Globofarm International, HUFORT HEALTHCARE, Nishchem, Pals Pharma and J B Khokhani, among others.
- Headquarter Delhi, India
- Employees 66
- Founders Nitin Aggarwal
- SectorsHealthcare
- Website deltrade.in
- Legal Name Del Trade International Private Limited
- Date of Incorporation 23 Aug, 2010
- Jurisdiction Delhi, India
- Annual Revenue₹526 Cr
FY 2025 · +4% YoY
- Net Profit₹2.16 Cr
FY 2025 · 0% margin
- EBITDA₹12.29 Cr
FY 2025 · 2% margin
- Employee Count66
Associated legal entities of Del Trade
Del Trade operates through Del Trade International Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Del Trade International Private Limited CIN U74999DL2010PTC207458 | Active | 23 Aug 2010 | Delhi, Delhi | ₹526 Cr | 66 | 4 | View details |
Board of directors of Del Trade International Private Limited (Del Trade)
Del Trade International Private Limited is the primary company behind Del Trade. The board of Del Trade International Private Limited currently have 4 directors; the longest-serving is Ramesh Gupta, appointed in 2010. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramesh Gupta DIN 00200169 | Managing Director | 23 Aug 2010 | 16 yrs 1 mo | Del Trade International Private Limited |
| Nitin Aggarwal DIN 03445940 | Director | 28 Feb 2011 | 15 yrs 7 mo | Del Trade International Private Limited |
| Charu Gupta DIN 06388860 | Director | 01 Sep 2012 | 14 yrs 1 mo | Del Trade International Private Limited |
| Piyush Sagar Gupta DIN 06933318 | Director | 24 Jul 2014 | 12 yrs 2 mo | Del Trade International Private Limited |
People of Del Trade
1 people are tracked at Del Trade (1 in leadership); the tracked headcount is 66.
| Name | Role | Group |
|---|---|---|
| Founder, Director | Leadership |
Complete people profiles for Del Trade
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Del Trade
Figures of Del Trade International Private Limited, the primary company behind Del Trade, for FY 2025. Revenue was ₹526 Cr (+4% year on year). Net profit was ₹2.16 Cr (0% margin). EBITDA was ₹12.29 Cr (2% margin). Revenue has grown at a compounded annual rate of +5% over three years and +13% over five years.
- ₹526 CrRevenue · FY 2025 · +4% YoY
- ₹2.16 CrNet profit · 0% margin
- ₹12.29 CrEBITDA · 2% margin
- ₹1.00 CrPaid-up capital
- 66Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Del Trade International Private Limited are on its company page.
Detailed financial statements for Del Trade
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Del Trade
Del Trade operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Globofarm International, HUFORT HEALTHCARE, Nishchem, Pals Pharma and J B Khokhani, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| globofarm.net | 2014 | Mumbai, India | – | – | Manufactures and supplies pharmaceutical ingredients and wellness products worldwide. | |
| hufort.in | 2007 | Mumbai, India | – | 6 | Distributes pharmaceutical raw materials through import, stock, and sales services. | |
| nishchem.com | 1990 | Mumbai, India | – | 15 | Manufactures and distributes pharmaceutical APIs and formulations globally with import and export services. | |
| palspharma.co.in | 2013 | Mumbai, India | – | – | Sourcing and marketing of pharmaceutical ingredients and products worldwide. | |
| jbkhokhani.com | 1965 | Mumbai, India | – | – | Distributes active pharmaceutical ingredients to industry clients. | |
| shaivyapharmachem.co.in | 2020 | Surat, India | – | – | Distributes pharmaceutical raw materials, intermediates, and chemicals worldwide. |
Detailed competitors of Del Trade
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Del Trade
The website of Del Trade (deltrade.in) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 13.4% vs previous month
Similar companies to Del Trade
10 companies that operate in the same segment as Del Trade (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Del Trade
Del Trade was founded in 2010.
Del Trade is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Del Trade has 66 employees.
The primary company behind Del Trade, Del Trade International Private Limited, reported revenue of ₹526 Cr for FY 2025, up 4% year on year.
Del Trade operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, distribution, and drug supply. Serves as a distributor of a wide range of pharmaceutical drugs. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Del Trade's top competitors include Globofarm International, HUFORT HEALTHCARE and Nishchem.
Del Trade operates through Del Trade International Private Limited.
The legal entities of Del Trade currently have 4 directors, including Nitin Aggarwal, Charu Gupta, Piyush Sagar Gupta and others.